COMPANY PROFILE

Xhale

Xhale and it's subsidiaries are transforming healthcare through the application of exhaled breath and novel vapor analysis in

Gainesville, United StatesFounded 2005Biotech & Life Sciences

Valuation $50–100M Last recorded · 2014

Total funding $10–50M Disclosed equity funding

Unlock exact values

About Xhale

Xhale, Inc. specializes in developing advanced breath-based medical technologies aimed at enhancing patient monitoring and ensuring medication adherence. The company operates in the healthcare sector, focusing on personalized medicine and point-of-need monitoring solutions. Xhale serves a diverse range of clients, including healthcare providers, pharmaceutical companies, and clinical trial organizations. Its business model revolves around creating novel patient-centric solutions that address unmet needs in the medical field. Xhale generates revenue through the sale of its innovative monitoring systems and related services, which help improve patient outcomes and streamline clinical trials. The company's management team boasts extensive experience and a proven track record of success, driving the firm’s commitment to quality, innovation, and excellence.

MoreLess Source: Dealroom company data

At a glance

Status: Operational
Founded: 2005
Headquarters: Gainesville, United States
Open positions: None listed
Dealroom signal: 50.5/100
Industry: Health
Sub-industry: BioTechnology, Medical Devices
Sector: Biotech & Life Sciences, Intellectual Property, Biotechnology, Spinout, Biotech and Pharma, DT and LS, science-based
Client focus: b2b
Links: Website

Knowledge graph

Founder mafia, market maps, research and news connected to this company by Dealroom

Funding history

7 recorded events

Company financing events and reported valuations.

Deal type	Date	Amount	Valuation	Investors	Source
DEBT✓Debt	Jul 2014	$4.6M	—	Undisclosed	—
GRANT✓Other financing	Apr 2014	$620K	—	National Institutes of Health	—

Showing the latest 2 of 7 recorded eventsBook a demo for the full funding history →

Growth signals

Xhale website traffic

Latest recorded traffic for Xhale is 260 monthly website visits, up 73.3% over the last three months.

Latest monthly visits260 3-month web change+73.3%

Monthly website visitsOct 2017–Jun 2024

Explore monthly traffic historyTrack growth over time and compare with peersBook a demo

Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Company	Headquarters	Status	Employees	Total funding	Valuation
AMAstute MedicalBy incoporating useful clinical tools, we help healthcare professionals provide rapid, accurate and life-saving responses	San Diego, United States	Acquired	39	$164M	$172M
SASanoculisStent-free minimally invasive surgical device for glaucoma	Kiryat Ono, Israel	Operational
NSNanoMedical SystemsNanoMedical Systems is developing a personalized molecular drug-delivery system that improves therapeutic outcomes	Austin, United States	Operational
MPMerrimack PharmaceuticalsMerrimack Pharmaceuticals discovers, designs and develops therapies for the treatment of diseases in the areas of autoimmunity and cancer	Cambridge, United States	Operational
TRTransAlgaeDevelops an algae-based platform for oral delivery of high value products for Animal Health and Crop Protection	Rehovot, Israel	Operational
QOQUE OncologyNovel therapies to address unmet medical needs in the treatment of cancer and its consequences	Melbourne, Australia	Operational
CTClinical Genomics TechnologiesInnovative products for colorectal cancer diagnosis	Bridgewater Township, United States	Operational
ABAndes BiotechnologiesLeading nucleic acid-based drug discovery and development company focused on solid tumor cancers	Santiago, Chile	Operational